title: Psychomotor development in congenital hypothyroidism. The Greek screening programme.
abstract: In 1979 a national screening programme for congenital hypothyroidism (CH) was introduced in Greece. Treatment with L-thyroxine was started immediately after confirmation of the diagnosis, at a median age of 28 days. A standardized development test (Griffiths) was given to a group of CH infants and to healthy controls at the ages of 5-7, 11-13, 17-19, and 23-25 months. Thirty-three infants with CH were also studied at the age of 35-37 months. The mean developmental quotient of CH infants was 103.8 +/- 12.0, 100.9 +/- 10.1, 103.3 +/- 7.1 and 99.8 +/- 10.2 from the ages of 5-7 to 23-25 months, and was not statistically different from those of the controls. Statistical analysis showed no significant differences between athyreotic children and those with an ectopic gland. Our findings show that the prognosis for psychomotor development of children with CH is quite good, provided that treatment starts in the first 6 weeks of life.
authors.affiliation: Paediatric Unit, Aghia Sophia Children's Hospital, Athens, Greece.
authors.forename: F
authors.initials: F
authors.lastname: Komianou
authors.forename: G
authors.initials: G
authors.lastname: Makaronis
authors.forename: J
authors.initials: J
authors.lastname: Lambadaridis
authors.forename: E
authors.initials: E
authors.lastname: Sarafidou
authors.forename: F
authors.initials: F
authors.lastname: Vrachni
authors.forename: C
authors.initials: C
authors.lastname: Mengreli
authors.forename: S
authors.initials: S
authors.lastname: Pantelakis
mesh_terms: D001846:Bone Development; D002675:Child, Preschool; D003409:Congenital Hypothyroidism; D006115:Greece; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000188:drug therapy; D007223:Infant; D008137:Longitudinal Studies; D008403:Mass Screening; D011597:Psychomotor Performance; D012959:Socioeconomic Factors; D013974:Thyroxine / Q000097:blood / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D013974:Thyroxine